Findings

What do systematic reviews say?

3 questions · 3 findings · 3 reviews · Hypertension

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 2 · 66.7%Low 1 · 33.3%Moderate 0 · 0%High 0 · 0%

Antihypertensive drug therapy vs placebo or no treatment

Withdrawals due to adverse events · adults (18 years of age or older) with hypertension‐induced left ventricular hypertrophy

It is very uncertain whether antihypertensive therapy changes withdrawal due to adverse events compared with placebo or no treatment (very low certainty).

1 finding from 1 review

Pharmacotherapy for hypertension‐induced left ventricular hypertrophy 2021 · Cochrane Headline outcomes only
RR 3.09 [1.69, 5.66]
1 study · 522 participants
Very low

All doses of cerivastatin vs placebo

Withdrawals due to adverse events · participants with normal or abnormal lipid profiles

It is very uncertain whether all doses of cerivastatin changes withdrawals due to adverse events compared with placebo (very low certainty).

1 finding from 1 review

Cerivastatin for lowering lipids 2020 · Cochrane Headline outcomes only
RR 1.09 [0.68, 1.74]
11 studies · 6570 participants
Very low

Uric acid lowering therapies (UAR) vs placebo

Withdrawals due to adverse events · hyperuricaemia in people with hypertension

Uric acid‐lowering drug showed no clear difference in adverse events (withdrawals due to side effects) compared with placebo (low certainty).

1 finding from 1 review

Pharmacotherapy for hyperuricaemia in hypertensive patients 2020 · Cochrane Headline outcomes only
RR 1.86 [0.43, 8.1]
3 studies · 241 participants
Low